Phospholamban Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Phospholamban monoclonal antibodies for research in cardiac physiology and cellular signaling. Phospholamban Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholamban is a critical regulator of cardiac muscle contraction, modulating the activity of the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA) and influencing calcium handling in cardiomyocytes. Understanding Phospholamban function is essential for investigating heart diseases and developing new therapeutic approaches. Research has shown that Phospholamban plays a vital role in maintaining proper cardiac rhythm and contractility. Dysregulation of Phospholamban has been linked to various cardiac conditions, making it a key focus in cardiovascular studies. Recent discoveries have highlighted Phospholamban's involvement in calcium homeostasis and its impact on heart failure development. Ongoing research continues to reveal new aspects of Phospholamban's role in cardiac health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance cardiovascular science and contribute to developing new therapeutic strategies for heart disease.